|
1
|
Bertuccio P, Chatenoud L, Levi F, Praud D,
Ferlay J, Negri E, Malvezzi M and La Vecchia C: Recent patterns in
gastric cancer: A global overview. Int J Cancer. 125:666–673. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.PubMed/NCBI
|
|
5
|
Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
6
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003–2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar
|
|
7
|
Shi Y and Zhou Y: The role of surgery in
the treatment of gastric cancer. J Surg Oncol. 101:687–692. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meyer HJ and Wilke H: Treatment strategies
in gastric cancer. Dtsch Arztebl Int. 108:698–705. 2011.PubMed/NCBI
|
|
9
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Celià-Terrassa T, Meca-Cortés O, Mateo F,
de Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A,
Guerra-Rebollo M, et al: Epithelial-mesenchymal transition can
suppress major attributes of human epithelial tumor-initiating
cells. J Clin Invest. 122:1849–1868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung JY, Davis JA, Price BD, Staley DM,
Wagner MV, Warner SL, Bearss DJ and Hansen MD: Competitive
enhancement of HGF-induced epithelial scattering by accessory
growth factors. Exp Cell Res. 317:307–318. 2011. View Article : Google Scholar
|
|
12
|
Saad RS, Ghorab Z, Khalifa MA and Xu M:
CDX2 as a marker for intestinal differentiation: Its utility and
limitations. World J Gastrointest Surg. 3:159–166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moskaluk CA, Zhang H, Powell SM, Cerilli
LA, Hampton GM and Frierson HF Jr: Cdx2 protein expression in
normal and malignant human tissues: An immunohistochemical survey
using tissue microarrays. Mod Pathol. 16:913–919. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park do Y, Srivastava A, Kim GH,
Mino-Kenudson M, Deshpande V, Zukerberg LR, Song GA and Lauwers GY:
CDX2 expression in the intestinal-type gastric epithelial
neoplasia: Frequency and significance. Mod Pathol. 23:54–61. 2010.
View Article : Google Scholar
|
|
15
|
Song JH, Kim CJ, Cho YG, Chae JS, Cao Z,
Nam SW, Lee JY and Park WS: Genetic alterations of the Cdx2 gene in
gastric cancer. APMIS. 116:74–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mizoshita T, Tsukamoto T, Nakanishi H,
Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y and Tatematsu M:
Expression of Cdx2 and the phenotype of advanced gastric cancers:
Relationship with prognosis. J Cancer Res Clin Oncol. 129:727–734.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Okayama H, Kumamoto K, Saitou K, Hayase S,
Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Sekikawa K, et
al: CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for
prediction of lymph node metastasis in primary gastric cancer.
Oncol Rep. 22:745–755. 2009.PubMed/NCBI
|
|
18
|
Qin R, Wang NN, Chu J and Wang X:
Expression and significance of homeodomain protein Cdx2 in gastric
carcinoma and precancerous lesions. World J Gastroenterol.
18:3296–3302. 2012.PubMed/NCBI
|
|
19
|
Wang XT, Wei WY, Kong FB, Lian C, Luo W,
Xiao Q and Xie YB: Prognostic significance of Cdx2
immunohistochemical expression in gastric cancer: A meta-analysis
of published literatures. J Exp Clin Cancer Res. 31:982012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang JF, Zhang JG, Kuai XL, Zhang H,
Jiang W, Ding WF, Li ZL, Zhu HJ and Mao ZB: Reactivation of the
homeotic tumor suppressor gene CDX2 by
5-aza-2′-deoxycytidine-induced demethylation inhibits cell
proliferation and induces caspase-independent apoptosis in gastric
cancer cells. Exp Ther Med. 5:735–741. 2013.PubMed/NCBI
|
|
21
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar
|
|
22
|
Xie Y, Li L, Wang X, Qin Y, Qian Q, Yuan X
and Xiao Q: Overexpression of Cdx2 inhibits progression of gastric
cancer in vitro. Int J Oncol. 36:509–516. 2010.PubMed/NCBI
|
|
23
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Książkiewicz M, Markiewicz A and Zaczek
AJ: Epithelial-mesenchymal transition: A hallmark in metastasis
formation linking circulating tumor cells and cancer stem cells.
Pathobiology. 79:195–208. 2012. View Article : Google Scholar
|
|
26
|
Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y,
Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T, et
al: Hypoxia stimulates the EMT of gastric cancer cells through
autocrine TGFβ signaling. PLoS One. 8:e623102013. View Article : Google Scholar
|
|
27
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elloul S, Vaksman O, Stavnes HT, Trope CG,
Davidson B and Reich R: Mesenchymal-to-epithelial transition
determinants as characteristics of ovarian carcinoma effusions.
Clin Exp Metastasis. 27:161–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumarswamy R, Mudduluru G, Ceppi P,
Muppala S, Kozlowski M, Niklinski J, Papotti M and Allgayer H:
MicroRNA-30a inhibits epithelial-tomesenchymal transition by
targeting Snai1 and is downregulated in non-small cell lung cancer.
Int J Cancer. 130:2044–2053. 2012. View Article : Google Scholar
|
|
30
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar :
|
|
31
|
Sarrio D, Rodriguez-Pinilla SM, Hardisson
D, Cano A, Moreno-Bueno G and Palacios J: Epithelial-mesenchymal
transition in breast cancer relates to the basal-like phenotype.
Cancer Res. 68:989–997. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Korpal M, Ell BJ, Buffa FM, Ibrahim T,
Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua
Y, et al: Direct targeting of Sec23a by miR-200s influences cancer
cell secretome and promotes metastatic colonization. Nat Med.
17:1101–1108. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kaimaktchiev V, Terracciano L, Tornillo L,
Spichtin H, Stoios D, Bundi M, Korcheva V, Mirlacher M, Loda M,
Sauter G, et al: The homeobox intestinal differentiation factor
CDX2 is selectively expressed in gastrointestinal adenocarcinomas.
Mod Pathol. 17:1392–1399. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Choi BJ, Kim CJ, Cho YG, Song JH, Kim SY,
Nam SW, Lee SH, Yoo NJ, Lee JY and Park WS: Altered expression of
CDX2 in colorectal cancers. APMIS. 114:50–54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bakaris S, Cetinkaya A, Ezberci F and
Ekerbicer H: Expression of homeodomain protein CDX2 in colorectal
adenoma and adenocarcinoma. Histol Histopathol. 23:1043–1047.
2008.PubMed/NCBI
|
|
36
|
Pancione M, Remo A, Sabatino L, Zanella C,
Votino C, Fucci A, Di Blasi A, Lepore G, Daniele B, Fenizia F, et
al: Right-sided rhabdoid colorectal tumors might be related to the
serrated pathway. Diagn Pathol. 8:312013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sakuma K, Aoki M and Kannagi R:
Transcription factors c-Myc and CDX2 mediate E-selectin ligand
expression in colon cancer cells undergoing EGF/bFGF-induced
epithelial-mesenchymal transition. Proc Natl Acad Sci USA.
109:7776–7781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo RJ, Suh ER and Lynch JP: The role of
Cdx proteins in intestinal development and cancer. Cancer Biol
Ther. 3:593–601. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fidler IJ and Poste G: The 'seed and soil'
hypothesis revisited. Lancet Oncol. 9:8082008. View Article : Google Scholar
|
|
41
|
Brabletz T, Jung A, Reu S, Porzner M,
Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable
beta-catenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:10356–10361. 2001. View Article : Google Scholar : PubMed/NCBI
|
